LETTER:Early AZT trials
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.From Dr Stephen Cameron
Sir: Steve Connor's Saturday Story (30 September), about the Delta trial of anti-HIV drugs taken in combination, made some remarks about the 1993 Concorde AZT trial that might mislead your readers into thinking there are no benefits to be had from AZT. The Concorde trial was designed to see if therapy with AZT, initiated early in the course of HIV-disease, when individuals are symptom-free, could extend the benefit of an increase in survival of 12 to 18 months, seen when AZT is taken later. The trial failed to find any advantage to early prescription, but this does not mean that AZT is not of benefit to Aids patients.
Yours faithfully,
Stephen Cameron
London, NW5
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments